Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Health Care Provider Use of Plasmodium Vivax Radical Cure (RC) With Tafenoquine or Primaquine After Semi-quantitative G6PD Testing: A Feasibility Study in Peru

NCT05361486 is registered in ClinicalTrials.gov with Medicines for Malaria Venture as lead sponsor.

NCT NCT05361486
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05361486 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Health Care Provider Use of Plasmodium Vivax Radical Cure (RC) With Tafenoquine or Primaquine After Semi-quantitative G6PD Testing: A Feasibility Study in Peru
Lead sponsor
Medicines for Malaria Venture
Phase
Observational
Overall status
Completed
Start date
August 28, 2023
Completion date
December 31, 2024
Enrollment
187 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malaria, vivax